$CNTX
Context Therapeutics Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Philadelphia, PA
CNTX chart
What traders are saying about $CNTX
Latest postsContext Therapeutics Inc. news
- Context Therapeutics Inc. Estimates – NASDAQ:CNTX
TradingView ·
- What Is the Funding Gap at Lunai (NASDAQ:LNAI), BranchOut Food (NASDAQ:BOF), Context Therapeutics (NASDAQ:CNTX) and Innovation Beverage (NASDAQ:IBG)?
Kalkine ·
- New Strong Sell Stocks for October 15th
Yahoo Finance ·
- New Strong Sell Stocks for October 13th
Yahoo Finance ·
- Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202
Yahoo Finance ·
- Context drops bispecific T-cell engager on cost-cutting initiative
pharmaceutical-technology.com ·
- Endometrial Cancer Market Share Analysis and Industry Trends (2026-2031) Featuring Merck, Eisai, Karyopharm Therapeutics, Context Therapeutics, Seagen and More
Yahoo Finance ·
- Context Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress
Yahoo Finance ·
- Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Context Therapeutics Added to Russell 2000® and Russell 3000® Indexes
Yahoo Finance ·
- Maxim Says Context Therapeutics (CNTX)’s Share Pullback Is an Overreaction; Remains Bullish
Yahoo Finance ·
- CNTX Hits Worst Day In History After Ovarian Cancer Trial Data — But Analysts See Buying Opportunity In Dip
stocktwits.com ·
Context Therapeutics Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$36.1M | -$26.7M | -$24.0M | -$14.8M |
| Diluted EPS | $-0.38 | $-0.46 | $-1.50 | $-0.93 |
| Total assets (year end) | $68.5M | $98.1M | $16.1M | $38.0M |
| Cash and equivalents (year end) | $66.0M | $94.4M | $14.4M | $35.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Context Therapeutics Inc.
- Ticker
- CNTX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Philadelphia, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1842952
- Former names
- Context Therapeutics LLC
Frequently asked questions
What exchange is Context Therapeutics Inc. listed on?
Context Therapeutics Inc. trades on the Nasdaq under the ticker symbol CNTX.
What industry is Context Therapeutics Inc. in?
Context Therapeutics Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Context Therapeutics Inc. headquartered?
Context Therapeutics Inc.'s business address on file with the SEC is in Philadelphia, PA.
When does Context Therapeutics Inc.'s fiscal year end?
Context Therapeutics Inc.'s fiscal year ends on December 31.